Topcon’s 3D OCT-1 Maestro Receives FDA Clearance in the U.S.

oct1

Topcon 3D OCT1_product02

Topcon Medical Systems (TMS) of Oakland, NJ is pleased to announce that the 3D OCT-1 Maestro™ is now available for sale in the United States. The 3D OCT-1 Maestro System delivers a new standard of clinical utility by combining a high resolution color non-mydriatic retinal camera with the latest Spectral Domain OCT technology. The rotating touch panel and fully automated (alignment, focus and capture) operation make the 3D OCT-1 Maestro the perfect diagnostic solution for even the smallest clinical practice.

PinPoint™ Registration properly indicates the location of the OCT image within the fundus image. A 12mm x 9mm scan along with automated segmentation provides measurement and topographical maps of the optic nerve and macula with Reference Database in one scan. The 3D OCT-1 Maestro also features a compare function, as well as automatic segmentation of RNFL, Total Retina, GCL + IPL, and GCL + IPL + RNFL with extensive Reference Database.

“We are very pleased to announce the availability of the 3D OCT-1 Maestro. The Maestro has been one of the best-selling SD OCTs outside the United States for the past 2 years and we are pleased that the recent FDA Clearance of the Maestro will now enable US eye care professionals to experience the benefits of the Maestro and contribute to their patient’s overall eye health and wellbeing,” stated John Fujita, President of Topcon Medical Systems. “With over 10,000 OCT’s sold by Topcon around the world, we are pleased that the 3D OCT-1 Maestro can now contribute to this impressive number of units sold and is now available for sale through several of Topcon’s US distributors and will be featured in the Topcon booth at ASRS on August 10-14 and at Vision Expo West on September 15-17.”

For more information on the Maestro, please visit newsgram.topconmedical.com/maestro.